Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (AAVXF) Operating Expenses (2024 - 2025)

Historic Operating Expenses for Abivax (AAVXF) over the last 2 years, with Q3 2025 value amounting to -$96.7 million.

  • Abivax's Operating Expenses fell 7100.73% to -$96.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.7 million, marking a year-over-year increase of 19612.21%. This contributed to the annual value of $198.2 million for FY2024, which is 3877.85% up from last year.
  • Latest data reveals that Abivax reported Operating Expenses of -$96.7 million as of Q3 2025, which was down 7100.73% from -$53.9 million recorded in Q2 2025.
  • In the past 5 years, Abivax's Operating Expenses ranged from a high of $346.0 million in Q4 2024 and a low of -$96.7 million during Q3 2025